Trial Profile
TOP -Study Telmisartan - Therapy of Hypertension and Life-style Changes in Cardiovascular Risk Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 10 Jul 2009 Actual initiation date (Jan 2007), actual patient number (5827) added as reported by ClinicalTrials.gov.
- 17 Oct 2007 New trial record.